Associations between integrase strand-transfer inhibitors and cardiovascular disease in people living with HIV: a multicentre prospective study from the RESPOND cohort consortium

Bastian Neesgaard(University of Copenhagen), Lene Ryom(University of Copenhagen), Colette Smith(MRC Clinical Trials Unit at UCL), Felipe Rogatto(Gilead Sciences (United States)), Marianna Menozzi(Azienda Ospedaliero-Universitaria di Modena), Gilles Wandeler(University of Bern), Annegret Pelchen–Matthews(University College London), Coca Necsoi(Centre Hospitalier Universitaire de Saint-Pierre), Jörg Janne Vehreschild(University Hospital Cologne), Loveleen Bansi‐Matharu, Katharina Grabmeier‐Pfistershammer, Antonella Castagna(Vita-Salute San Raffaele University), Alain Volny Anne(Treatment Action Group), Robert Zangerle(Universität Innsbruck), Huldrych F. Günthard(University of Zurich), José M. Miró(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Line Dahlerup Rasmussen(Odense University Hospital), Christian Pradier(Université Côte d'Azur), Amanda Mocroft(University of Copenhagen), H Garges(Triangle), Antonella d’Arminio Monforte(University of Milan), Jens Lundgren(Centre of Excellence for Health, Immunity and Infections), Lauren Greenberg(Queen Mary University of London), Marc van der Valk(Academic Medical Center), Stéphane De Wit(Université Libre de Bruxelles), Lars Peters(University of Copenhagen), Cristina Mussini(University of Modena and Reggio Emilia), Anders Sönnerborg(Karolinska Institutet), Andrew Carr(St Vincent's Hospital Sydney), Ferdinand Wit(Stichting HIV Monitoring), Camilla Muccini(Vita-Salute San Raffaele University)
The Lancet HIV
June 7, 2022
Cited by 140


Related Papers